Loading clinical trials...
Loading clinical trials...
Intracranial atherosclerotic disease (ICAD) is an important cause of ischemic stroke. The occurrence of stroke caused by symptomatic ICAD is significantly different compared with asymptomatic ICAD (19...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Xiuhai Guo
NCT05316311 · Intracranial Atherosclerosis
NCT06902740 · Intracranial Atherosclerosis, Intracranial Artery Stenosis, and more
NCT04948749 · ICAD - Intracranial Atherosclerotic Disease, ICAS - Intracranial Atherosclerosis, and more
NCT06610578 · Intracranial Atherosclerosis
NCT04627870 · Intracranial Atherosclerosis, Stroke
Department of Neurology, Xuanwu hospital
Beijing, Beijing Municipality
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions